Cargando…
The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer
BACKGROUND: While both preclinical and clinical studies suggest that the frequency of growing skeletal metastases is elevated in individuals with higher bone turnover, it is unclear whether this is a result of increased numbers of tumour cells arriving in active sites or of higher numbers of tumour...
Autores principales: | Wang, Ning, Reeves, Kimberley J., Brown, Hannah K., Fowles, Anne C M, Docherty, Freyja E., Ottewell, Penelope D., Croucher, Peter I., Holen, Ingunn, Eaton, Colby L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615337/ https://www.ncbi.nlm.nih.gov/pubmed/26480944 http://dx.doi.org/10.1186/s13046-015-0240-8 |
Ejemplares similares
-
Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer
por: Brown, Hannah K., et al.
Publicado: (2018) -
The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche in vivo
por: Allocca, Gloria, et al.
Publicado: (2019) -
The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells
por: Brown, Hannah K, et al.
Publicado: (2011) -
Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention
por: Quayle, Lewis A., et al.
Publicado: (2018) -
The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
por: Wilson, Caroline, et al.
Publicado: (2015)